	US 12,115,181 B2
	Administration of citicoline to improve cognitive performance, attentional performance, and motor function
Deborah Yurgelun-Todd, Salt Lake City, UT (US); Perry Renshaw, Salt Lake City, UT (US); Miho Takada, Tokyo (JP); Takeshi Ikeda, Tokyo (JP); and Masahiko Morita, Tokyo (JP)
Assigned to KYOWA HAKKO BIO CO., LTD., Tokyo (JP)
Filed by KYOWA HAKKO BIO CO., LTD., Tokyo (JP)
Filed on Dec. 21, 2022, as Appl. No. 18/069,325.
Application 18/069,325 is a continuation of application No. 15/307,411, granted, now 11,583,546, previously published as PCT/IB2015/053178, filed on Apr. 30, 2015.
Claims priority of provisional application 61/986,502, filed on Apr. 30, 2014.
Prior Publication US 2023/0181614 A1, Jun. 15, 2023
Int. Cl. A61K 31/7068 (2006.01); A61K 9/00 (2006.01); A61K 31/6615 (2006.01)

CPC A61K 31/7068 (2013.01) [A61K 9/0053 (2013.01); A61K 31/6615 (2013.01)]

12 Claims

1. A method for improving visual attention of a healthy human subject comprising a step of administering an effective amount of citidine-5′-diphosphocholine or a salt thereof to a healthy human subject, wherein speed and accuracy of visual attention are improved.